• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全基因组测序揭示了导致常染色体显性遗传性阿尔波特综合征的一种新型结构变异:病例报告。

Whole-genome sequencing revealed a novel structural variant in causing autosomal dominant Alport syndrome: A case report.

作者信息

Delage Clément, Andreani Marine, Boukrout Nihad, Sabaouni Naoual, Perrais Michaël, Lefebvre Bruno, Cauffiez Christelle, Pottier Nicolas, Larrue Romain

机构信息

Service de Toxicologie et Génopathies, CHU Lille, F-59000, Lille, France.

Service de Néphrologie, CHU de Nice, F-06000, Nice, France.

出版信息

Heliyon. 2024 Nov 28;10(24):e40802. doi: 10.1016/j.heliyon.2024.e40802. eCollection 2024 Dec 30.

DOI:10.1016/j.heliyon.2024.e40802
PMID:39735618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11681849/
Abstract

Next-generation sequencing has substantially transformed the genomic diagnosis of individuals affected by inherited renal disorders. Indeed, accurate and rapid diagnostic for patients with suspected genetic kidney diseases is not only important for prognosis and patient management but also for family counseling. Alport syndrome, a genetic disease primarily affecting the basement membrane, is characterized by hematuria, progressive kidney failure, hearing impairment, as well as ocular abnormalities and stems from mutations in genes encoding type IV collagen. In this study, we show the benefit of whole-genome sequencing for the molecular diagnosis of a dominant form of Alport syndrome by identifying a novel heterozygous pathogenic structural variant in a family with three affected members. This case underscores the potential of whole-genome sequencing as a frontline diagnostic approach for inherited kidney diseases and further indicates that structural variations represent an important cause of monogenic disorders.

摘要

下一代测序技术已极大地改变了对遗传性肾脏疾病患者的基因组诊断。事实上,对疑似遗传性肾病患者进行准确、快速的诊断不仅对预后和患者管理很重要,对家族咨询也很重要。阿尔波特综合征是一种主要影响基底膜的遗传性疾病,其特征为血尿、进行性肾衰竭、听力障碍以及眼部异常,由编码IV型胶原的基因突变引起。在本研究中,我们通过在一个有三名患病成员的家庭中鉴定出一种新的杂合致病性结构变异,展示了全基因组测序对显性阿尔波特综合征分子诊断的益处。该病例强调了全基因组测序作为遗传性肾病一线诊断方法的潜力,并进一步表明结构变异是单基因疾病的一个重要病因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d36d/11681849/b33b889e0919/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d36d/11681849/b33b889e0919/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d36d/11681849/b33b889e0919/gr1.jpg

相似文献

1
Whole-genome sequencing revealed a novel structural variant in causing autosomal dominant Alport syndrome: A case report.全基因组测序揭示了导致常染色体显性遗传性阿尔波特综合征的一种新型结构变异:病例报告。
Heliyon. 2024 Nov 28;10(24):e40802. doi: 10.1016/j.heliyon.2024.e40802. eCollection 2024 Dec 30.
2
Novel heterozygous mutation in responsible for Alport syndrome in a Chinese family.一个中国家庭中导致奥尔波特综合征的新杂合突变。
Front Genet. 2022 Sep 9;13:899006. doi: 10.3389/fgene.2022.899006. eCollection 2022.
3
Identification of a Novel Variant in Compound-Heterozygous State in a Patient With Alport Syndrome and Histological Findings Similar to Focal Segmental Glomerulosclerosis (FSGS).在一名患有Alport综合征且组织学表现类似于局灶节段性肾小球硬化(FSGS)的患者中鉴定出处于复合杂合状态的新型变异体。
Front Genet. 2019 Jan 28;9:748. doi: 10.3389/fgene.2018.00748. eCollection 2018.
4
Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.常染色体显性遗传性奥尔波特综合征患者的遗传、临床及病理背景
Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1441-1449. doi: 10.2215/CJN.01000116. Epub 2016 Jun 8.
5
Potential Founder Variants in COL4A4 Identified in Bukharian Jews Linked to Autosomal Dominant and Autosomal Recessive Alport Syndrome.在与常染色体显性遗传和常染色体隐性遗传 Alport 综合征相关的布哈拉犹太人中鉴定到 COL4A4 的潜在致病变异。
Genes (Basel). 2023 Sep 23;14(10):1854. doi: 10.3390/genes14101854.
6
A Novel Loss-of-Function Variant in COL4A3 in a Consanguineous Moroccan Family Displaying the Alport Syndrome with Variable Clinical Expression.在一个患有临床表现各异的奥尔波特综合征的摩洛哥近亲家庭中,发现COL4A3基因存在一种新型功能丧失变异。
Mol Syndromol. 2025 Feb;16(1):43-48. doi: 10.1159/000540122. Epub 2024 Jul 24.
7
COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.薄基底膜肾病中的COL4A4突变,先前在Alport综合征中已有描述。
Kidney Int. 2001 Aug;60(2):480-3. doi: 10.1046/j.1523-1755.2001.060002480.x.
8
Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.常染色体显性遗传性奥尔波特综合征:COL4A4基因的分子分析及临床结果
Nephrol Dial Transplant. 2009 May;24(5):1464-71. doi: 10.1093/ndt/gfn681. Epub 2009 Jan 7.
9
Identification of 27 Novel Variants in Genes , and in Lithuanian Families With Alport Syndrome.在立陶宛阿尔波特综合征家族中鉴定出基因、和中的27个新变异体。
Front Med (Lausanne). 2022 Mar 28;9:859521. doi: 10.3389/fmed.2022.859521. eCollection 2022.
10
Kidney Disease Associated With Mono-allelic and Variants: A Case Series of 17 Families.与单等位基因和变异相关的肾脏疾病:17个家庭的病例系列
Kidney Med. 2023 Feb 1;5(4):100607. doi: 10.1016/j.xkme.2023.100607. eCollection 2023 Apr.

本文引用的文献

1
Alport Syndrome: A Comprehensive Review.奥尔波特综合征:全面综述
Cureus. 2023 Oct 16;15(10):e47129. doi: 10.7759/cureus.47129. eCollection 2023 Oct.
2
Alport Syndrome: Clinical Spectrum and Therapeutic Advances.奥尔波特综合征:临床谱与治疗进展
Kidney Med. 2023 Mar 21;5(5):100631. doi: 10.1016/j.xkme.2023.100631. eCollection 2023 May.
3
Whole-genome sequencing of 1029 Indian individuals reveals unique and rare structural variants.对 1029 名印度个体的全基因组测序揭示了独特而罕见的结构变异。
J Hum Genet. 2023 Jun;68(6):409-417. doi: 10.1038/s10038-023-01131-7. Epub 2023 Feb 22.
4
Mechanisms of structural chromosomal rearrangement formation.结构性染色体重排形成的机制。
Mol Cytogenet. 2022 Jun 14;15(1):23. doi: 10.1186/s13039-022-00600-6.
5
Genetic Basis of Type IV Collagen Disorders of the Kidney.肾脏 IV 型胶原疾病的遗传基础。
Clin J Am Soc Nephrol. 2021 Jul;16(7):1101-1109. doi: 10.2215/CJN.19171220. Epub 2021 Apr 13.
6
Alport Syndrome Classification and Management.奥尔波特综合征的分类与管理
Kidney Med. 2020 Aug 7;2(5):639-649. doi: 10.1016/j.xkme.2020.05.014. eCollection 2020 Sep-Oct.
7
Diagnostic utility of whole-genome sequencing for nephronophthisis.全基因组测序在肾单位肾痨中的诊断效用。
NPJ Genom Med. 2020 Sep 21;5:38. doi: 10.1038/s41525-020-00147-8. eCollection 2020.
8
Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).《常染色体拷贝数变异解释和报告的技术标准:美国医学遗传学与基因组学学会(ACMG)与临床基因组资源(ClinGen)的联合共识推荐》
Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
9
Delivering genome sequencing in clinical practice: an interview study with healthcare professionals involved in the 100 000 Genomes Project.在临床实践中进行基因组测序:一项对参与 10 万基因组计划的医疗保健专业人员的访谈研究。
BMJ Open. 2019 Nov 3;9(11):e029699. doi: 10.1136/bmjopen-2019-029699.
10
Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.估算罕见病的累计点患病率:对孤儿药数据库的分析。
Eur J Hum Genet. 2020 Feb;28(2):165-173. doi: 10.1038/s41431-019-0508-0. Epub 2019 Sep 16.